| Application no. and date | 98906688.1 (espacenet) (Federated) (European Patent Register), 19980211 | | Patent/reg. no. and date | DK/EP 1007055, 20040204 | | Publication date | 20000614 | | Priority no. and date | US 798840, 19970212 | | EP pub. no. and date |
EP 1007055 20000614 | | Effective date | | | Applicant/owner | MedImmune Oncology, Inc., One MedImmune Way
Gaithersburg, MD 20878, US | | Applicant ref. no. | 118759 | | Inventor | STOGNIEW, Martin, 1870 Ferguson Lane
Blue Bell, PA 19422, US,
SCHEIN, Philip, S., 605 Old Gulph Road
Bryn Mawr, PA 19010, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 31/13, A61P 43/00, A61K 31/66 | | Title | Anvendelse af amifostin | | Int. application no. | US1998003614 | | Int. publication no. | WO1998034622 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
